Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Jakavi 5 mg Tablet
Manufacturer/Marketed By : Novartis Healthcare Pvt Ltd
$258.14 $237.99
Jakavi 5 mg Tablet is a specialized medication classified as a Janus kinase inhibitor, designed to effectively treat intermediate to high-risk Myelofibrosis, a rare form of bone marrow cancer, as...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Ruxolitinib 5 mg
Active Pharmaceutical Ingredient
Jakavi 5 mg Tablet
258.14$
237.99$
Jakavi 5 mg Tablet is a specialized medication classified as a Janus kinase inhibitor, designed to effectively treat intermediate to high-risk Myelofibrosis, a rare form of bone marrow cancer, as well as Polycythemia Vera, a condition marked by excessive red blood cell production. This innovative treatment works by disrupting abnormal signaling pathways that contribute to these disorders, helping to alleviate symptoms and improve overall blood cell counts. Before starting therapy with Jakavi, it is crucial to conduct a blood cell count to ensure safe usage and monitor treatment efficacy. This medication is not recommended for individuals under 12 years old, as its safety and effectiveness in this age group have not been established. Patients should consult with their healthcare provider regarding potential side effects and necessary precautions. By adhering to prescribed guidelines and monitoring, Jakavi 5 mg Tablet can play a vital role in managing these complex hematologic conditions, leading to improved patient outcomes. Always follow your doctor's advice and discuss any concerns you may have regarding this treatment option.
Active Pharmaceutical Ingredient
Uses
• Jakavi 5 mg tablet is primarily indicated for the treatment of polycythemia vera, a condition characterized by an overproduction of red blood cells. By helping to regulate blood cell production, Jakavi 5 mg tablet assists in normalizing blood viscosity. This can improve blood flow and reduce the risk of complications associated with thickened blood. Patients using Jakavi 5 mg tablet often experience enhanced overall well-being due to better blood circulation.
• In patients with polycythemia vera, Jakavi 5 mg tablet works by targeting the underlying mechanisms of the disease. This targeted approach not only helps manage symptoms but also aids in reducing the likelihood of serious complications like blood clots. Regular use of Jakavi 5 mg tablet can lead to a more stable blood cell count. As a result, individuals may find it easier to manage daily activities without the fatigue often associated with this condition.
• Jakavi 5 mg tablet is beneficial for those who have not responded adequately to other treatments for polycythemia vera. It offers an alternative option for managing this rare blood disorder effectively. By using Jakavi 5 mg tablet, healthcare providers can tailor treatment plans to better meet the needs of their patients. This personalized approach can lead to improved patient outcomes and quality of life.
• The administration of Jakavi 5 mg tablet is designed to provide long-term management of polycythemia vera. Patients may find that consistent use contributes to the stabilization of their condition. This stability can help in reducing the frequency of medical interventions and hospital visits. Overall, Jakavi 5 mg tablet plays a crucial role in the ongoing care of individuals with this blood disorder.
Benefits
Jakavi 5 mg Tablet can be effective in reducing symptoms associated with myelofibrosis, such as fatigue, enlarged spleen, and uncontrolled bleeding
Jakavi 5 Tablet may improve the overall quality of life and reduce the symptoms of myelofibrosis.
Jakavi 5 mg Tablet has been shown to reduce bone marrow fibrosis (scarring) in those with myelofibrosis. Jakavi 5 mg Tablet prevent cancer in those with myelofibrosis and help to prevent the progression of myelofibrosis to acute myeloid leukaemia (AML).
Side Effects
Like all medicines, Jakavi 5 Tablet may have side effects. If you experience any, it's important to contact your doctor or healthcare provider as soon as possible. They may be able to offer strategies to help manage or reduce the severity of these side effects.
Most Common Side Effects
• Headache
• dizziness
• Weight gain
• High blood pressure
• High cholesterol
• Flatulence
• Abnormal liver function tests
• Difficulty in breathing
• Constipation
Common Side Effects
• Decrease in red blood cells
• Infection
How To Use
You can take Jakavi 5 mg with or without food. Make sure that you take it at the same time of the day every day. Swallow the pill entirely with a drink of water. Do not crush, chew or open the tablet. If you miss a dose of this medicine, take it as soon as you remember to do so. Skip the missed dose and resume your regular dosing schedule if it's almost time for your next dose. To make up for a missed dose, do not take two doses at once.
Safety Advice
• Alcohol: It's a good idea to avoid drinking alcohol while taking Jakavi 5 mg Tablet. Alcohol may increase the risk of side effects or decrease the effectiveness of Jakavi 5 mg. For your safety, consult your doctor or pharmacist before mixing alcohol with any medication.
• Kidney: Patients with kidney disease should use Jakavi 5 mg Tablet with caution. It's important for these patients to monitor their kidney function regularly while taking Jakavi 5 mg and to report any unusual symptoms or changes to their healthcare provider immediately. Dosage adjustments for Jakavi 5 Tablet may be necessary in individuals with kidney disease.
• Breastfeeding: Breastfeeding while using Jakavi 5 mg Tablet is generally not recommended as Jakavi 5 Tablet can pass into breast milk and potentially harm your baby. If you're currently breastfeeding and using Jakavi 5 mg, it's important to consult your doctor. They can discuss the potential risks and benefits with you and help you make the best choice for you and your baby.
• Liver: Patients with liver disease should use Jakavi 5 mg Tablet cautiously. It's important for these people to monitor their liver function regularly while using Jakavi 5 Tablet and to tell their doctor immediately of any unusual symptoms or changes. The dose of Jakavi 5 mg may need to be adjusted in people with liver disease.
• Pregnancy: Using Jakavi 5 mg Tablet during pregnancy may be risky as animal studies have shown that it may have adverse effects on the developing foetus. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of taking Jakavi 5 Tablet with your doctor. Your doctor can help you make the best decision for your health and the health of your baby.
• Driving: Using Jakavi 5 mg Tablet may cause dizziness, fatigue, and problems with concentration or coordination, which may affect your ability to drive safely. It's important to follow your doctor's advice and take the necessary precautions, such as not driving or operating heavy machinery, if you experience these side effects from Jakavi 5 Tablet.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.